AAAAAA
Results:
1-9
|
Results: 9
Authors:
Resbeut, MR
Alzieu, C
Gonzague-Casabianca, L
Badinand, D
Bardou, VJ
Cravello, L
Gamerre, M
Houvenaeghel, G
Cowen, D
Citation: Mr. Resbeut et al., Combined brachytherapy and surgery for early carcinoma of the uterine cervix: Analysis of extent of surgery on outcome, INT J RAD O, 50(4), 2001, pp. 873-881
Authors:
Cutuli, B
Borel, C
Dhermain, F
Magrini, SM
Wasserman, TH
Bogart, JA
Provencio, M
de Lafontan, B
de la Rochefordiere, A
Cellai, E
Graic, Y
Kerbrat, P
Alzieu, C
Teissier, E
Dilhuydy, JM
Mignotte, H
Velten, M
Citation: B. Cutuli et al., Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases, RADIOTH ONC, 59(3), 2001, pp. 247-255
Authors:
Alzieu, C
Citation: C. Alzieu, Impact of tributyltin on marine invertebrates, ECOTOXICOL, 9(1-2), 2000, pp. 71-76
Authors:
Protiere, C
Viens, P
Genre, D
Cowen, D
Camerlo, J
Gravis, G
Alzieu, C
Bertucci, F
Resbeut, M
Maraninchi, D
Moatti, JP
Citation: C. Protiere et al., Patient participation in medical decision-making: A French study in adjuvant radio-chemotherapy for early breast cancer, ANN ONCOL, 11(1), 2000, pp. 39-45
Authors:
Cutuli, B
Janvier, M
de la Rochefordiere, A
Julien, JP
Isambert, N
Alzieu, C
Kerbrat, P
de Lafontan, B
van Lemmens, L
Cure, H
Ganem, G
Baume, D
Le Mevel, A
Lorthoraly, A
de Gislain, C
Marchal, C
Chevelle, C
Lauche, H
Serin, D
Citation: B. Cutuli et al., Leukemias and preleukemic states developing after treatment of breast cancer, PRESSE MED, 29(3), 2000, pp. 135-138
Authors:
Bouabdallah, R
Coso, D
Gonzague-Casabianca, L
Alzieu, C
Resbeut, M
Gastaut, JA
Citation: R. Bouabdallah et al., Safely and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients, LEUK RES, 24(6), 2000, pp. 491-495
Authors:
Alzieu, C
Citation: C. Alzieu, Environmental impact of TBT: the french experience, SCI TOTAL E, 258(1-2), 2000, pp. 99-102
Authors:
Gravis, G
Pech-Gourgh, F
Viens, P
Alzieu, C
Camerlo, J
Oziel-Taieb, S
Jausseran, M
Maraninchi, D
Citation: G. Gravis et al., Phase II study of a combination of low-dose cisplatin with 13-cis-retinoicacid and interferon-alpha in patients with advanced head and neck squamouscell carcinoma, ANTI-CANC D, 10(4), 1999, pp. 369-374
Authors:
Bouabdallah, R
Stoppa, AM
Rossi, JF
Lepeu, G
Coso, D
Xerri, L
Ladaique, P
Chabannon, C
Blaise, D
Bardou, VJ
Alzieu, C
Gastaut, JA
Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
Risultati:
1-9
|